Batavia Bioservices aims to significantly contribute to ease human suffering from disease by improving the success rate in the translation of candidate medicines from discovery to the clinic.
In the rapidly growing market of biopharmaceuticals we offer our novel technologies and know how in order to help our customers to complete their preclinical phases in product development at higher speed, reduced cost, and with higher success rate.
read more >>
New vacancies
Leiden, April 13th, 2012
Currently we are looking for a:
- (Senior) Technician R&D Department and
- Scientists USP and DSP.
read more >>
Batavia Bioservices launches laboratory infrastructure in Greater Boston area
Leiden, April 3rd, 2012
As of February 2012 Batavia Bioservices deploys 5.300 square feet of laboratories at 300 TradeCenter, Suite 6650, Woburn, MA 01801.
read more >>
Batavia Bioservices has been awarded a prestigious European grant
Leiden, January 2nd, 2012
Batavia Bioservices is proud to announce that it has been awarded a prestigious European grant (FP7-program) UNDER THE MARIE CURIE INITIAL TRAINING NETWORK (ITN).
read more >>
Batavia Bioservice will participate in a grant from the Bill and Melinda Gates Foundation
Leiden, January 2nd, 2012
Batavia Bioservices is proud to announce that the company will participate in a prestigious grant from the Bill and Melinda Gates Foundation awarded to Beth Israel Deaconess Medical Center (BIDMC), a major teaching hospital of Harvard Medical School.
read more >>
Batavia Bioservices offers a portfolio of services focused on the rapid and cost effective provision of high quality biopharmaceutical materials for research and pre-clinical studies. Services include:
Batavia Bioservices is strongly committed to the development of new technologies and innovations within the field of biopharmaceutical research and development. We focus on technology which ultimately leads to the development of better medicines at reduced cost and time.